SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Not all “quality-adjusted life years” are equal
13 references·3 citing·44 second hop
Not all “quality-adjusted life years” are equal (2006)Not all “quality-adjusted life years” are…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden (2004)Cost effectiveness of adalimu…A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis (2004)A comparison of generic, indi…A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis (2004)A Comparison of Four Indirect…Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments (2003)Variation in the Estimation o…The cost‐effectiveness of infliximab (Remicade®) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study (2003)The cost‐effectiveness of inf…Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK (2003)Modelling the cost-effectiven…A comparative review of four preference-weighted measures of health-related quality of life (2003)A comparative review of four …Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Thinking Outside the Box: Rec…Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis (2002)Estimating the cost-effective…Valuing Health-Related Quality of Life (2000)Valuing Health-Related Qualit…A Comparison of HU12 and HU13 Utility Scores in Alzheimer's Disease (2000)A Comparison of HU12 and HU13…A Comparative Review of Generic Quality-of-Life Instruments (2000)A Comparative Review of Gener…Adult Measures of General Health and Health‐Related Quality of Life (2020)Adult Measures of General Hea…A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes? (2012)A comparison of the ICECAP-O …Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? (2008)Do estimates of cost-utility …A power primer. (1992)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQ O L) (2011)The minimum clinically important difference for EQ-5D index: a critical review (2014)A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D (2018)Prospect Theory: An Analysis of Decision under Risk (1979)STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT (1986)Prospect theory: An analysis of decision under risk (1988)Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders (2008)Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D (2010)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)EuroQol - a new facility for the measurement of health-related quality of life (1990)The health status of the Dutch population as assessed by the EQ-6D (2005)Guidelines for the Conduction of Follow-up Studies Measuring Injury-Related Disability (2007)Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review (2008)Department of Labor (1941)Markov Models in Medical Decision Making (1993)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry (2007)The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review (2015)Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) (1997)A comparison of the EQ‐5D and SF‐6D across seven patient groups (2004)Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis (2008)The Measurement of Observer Agreement for Categorical Data (1977)The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies (2001)Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency department (2012)EuroQol-5D (EQ-5D): an instrument for measuring quality of life (2015)Methods for the economic evaluation of health care programmes (1987)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Cost-Effectiveness in Health and Medicine (1996)EuroQol: the current state of play (1996)Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis (2005)Statistical principles in experimental design. (1962)The Framing of Decisions and the Psychology of Choice (1981)Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. (2006)Theory of games and economic behavior (2019)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 2000A Comparative Review of Generic Quality-of-Life Instruments824 cited
  • 2002Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies404 cited
  • 2004A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis398 cited
  • 2000Valuing Health-Related Quality of Life222 cited
  • 2003A comparative review of four preference-weighted measures of health-related quality of life216 cited
  • 2003Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK175 cited
  • 2003The cost‐effectiveness of infliximab (Remicade®) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study160 cited
  • 2003Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments146 cited
  • 2002Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis128 cited
  • 2004A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis123 cited
  • 2004Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden121 cited
  • 2000A Comparison of HU12 and HU13 Utility Scores in Alzheimer's Disease

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

104 cited

Cited by

  • 2012A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?98 cited
  • 2008Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?85 cited
  • 2020Adult Measures of General Health and Health‐Related Quality of Life77 cited